Cardinal Health (CAH) reveals promising news as it has reported strong earnings, exceeded revenue expectations, and outlined growth optimism. The company's
successful Q3 invokes renewed attention towards its valuation.
Jim Cramer lauds the company calling it 'Value-Added'. CAH's announcement of Q1 results for
fy 2026 on Oct 30 is eagerly awaited alongside its announcement of Q4 results for fy 2025. The company’s major
acquisition of Solaris Health enhances its portfolio significantly. CAH's expansion to Japan and Indianapolis has been well-received. The company's stock price surge can be attributed to its impressive Q1 earnings and revenue estimates, resulting in CAH reaching a new 52-week high.
Strong momentum within the company has spurred discussions about the stock's valuation. Plans revealed during the Investor Day indicate that CAH is poised for long-term value creation. The
positive Q3 report has led to a 10.7% jump in stock. Institutional investors are reaping benefits from the company’s performance, with a 16% stock surge observed over the week.
Cardinal Health CAH News Analytics from Thu, 01 May 2025 07:00:00 GMT to Sat, 22 Nov 2025 21:11:44 GMT -
Rating 8
